• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度北部前列腺癌患者中ETS和非ETS畸变的分子特征分析。

Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India.

作者信息

Ateeq Bushra, Kunju Lakshmi P, Carskadon Shannon L, Pandey Swaroop K, Singh Geetika, Pradeep Immanuel, Tandon Vini, Singhai Atin, Goel Apul, Amit Sonal, Agarwal Asha, Dinda Amit K, Seth Amlesh, Tsodikov Alexander, Chinnaiyan Arul M, Palanisamy Nallasivam

机构信息

Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, India.

Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan.

出版信息

Prostate. 2015 Jul 1;75(10):1051-62. doi: 10.1002/pros.22989. Epub 2015 Mar 23.

DOI:10.1002/pros.22989
PMID:25809148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4832366/
Abstract

BACKGROUND

Molecular stratification of prostate cancer (PCa) based on genetic aberrations including ETS or RAF gene-rearrangements, PTEN deletion, and SPINK1 over-expression show clear prognostic and diagnostic utility. Gene rearrangements involving ETS transcription factors are frequent pathogenetic somatic events observed in PCa. Incidence of ETS rearrangements in Caucasian PCa patients has been reported, however, occurrence in Indian population is largely unknown. The aim of this study was to determine the prevalence of the ETS and RAF kinase gene rearrangements, SPINK1 over-expression, and PTEN deletion in this cohort.

METHODS

In this multi-center study, formalin-fixed paraffin embedded (FFPE) PCa specimens (n = 121) were procured from four major medical institutions in India. The tissues were sectioned and molecular profiling was done using immunohistochemistry (IHC), RNA in situ hybridization (RNA-ISH) and/or fluorescence in situ hybridization (FISH).

RESULTS

ERG over-expression was detected in 48.9% (46/94) PCa specimens by IHC, which was confirmed in a subset of cases by FISH. Among other ETS family members, while ETV1 transcript was detected in one case by RNA-ISH, no alteration in ETV4 was observed. SPINK1 over-expression was observed in 12.5% (12/96) and PTEN deletion in 21.52% (17/79) of the total PCa cases. Interestingly, PTEN deletion was found in 30% of the ERG-positive cases (P = 0.017) but in only one case with SPINK1 over-expression (P = 0.67). BRAF and RAF1 gene rearrangements were detected in ∼1% and ∼4.5% of the PCa cases, respectively.

CONCLUSIONS

This is the first report on comprehensive molecular profiling of the major spectrum of the causal aberrations in Indian men with PCa. Our findings suggest that ETS gene rearrangement and SPINK1 over-expression patterns in North Indian population largely resembled those observed in Caucasian population but differed from Japanese and Chinese PCa patients. The molecular profiling data presented in this study could help in clinical decision-making for the pursuit of surgery, diagnosis, and in selection of therapeutic intervention.

摘要

背景

基于包括ETS或RAF基因重排、PTEN缺失以及SPINK1过表达等基因异常的前列腺癌(PCa)分子分层显示出明确的预后和诊断价值。涉及ETS转录因子的基因重排是在PCa中观察到的常见致病体细胞事件。白种人PCa患者中ETS重排的发生率已有报道,然而,在印度人群中的发生情况在很大程度上尚不清楚。本研究的目的是确定该队列中ETS和RAF激酶基因重排、SPINK1过表达以及PTEN缺失的患病率。

方法

在这项多中心研究中,从印度的四个主要医疗机构获取了福尔马林固定石蜡包埋(FFPE)的PCa标本(n = 121)。将组织切片并使用免疫组织化学(IHC)、RNA原位杂交(RNA-ISH)和/或荧光原位杂交(FISH)进行分子谱分析。

结果

通过IHC在48.9%(46/94)的PCa标本中检测到ERG过表达,在一部分病例中通过FISH得到了证实。在其他ETS家族成员中,虽然通过RNA-ISH在1例中检测到ETV1转录本,但未观察到ETV4的改变。在所有PCa病例中,12.5%(12/96)观察到SPINK1过表达,21.52%(17/79)观察到PTEN缺失。有趣的是,在30%的ERG阳性病例中发现了PTEN缺失(P = 0.017),但在只有1例SPINK1过表达的病例中发现了PTEN缺失(P = 0.67)。在约1%和约4.5%的PCa病例中分别检测到BRAF和RAF1基因重排。

结论

这是关于印度男性PCa主要病因异常综合分子谱分析的首份报告。我们的研究结果表明,北印度人群中的ETS基因重排和SPINK1过表达模式在很大程度上与白种人人群中观察到的相似,但与日本和中国的PCa患者不同。本研究中呈现的分子谱分析数据有助于在手术、诊断以及治疗干预选择方面的临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce4b/4832366/609024911a8c/PROS-75-1051-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce4b/4832366/7c7d2f4406e7/PROS-75-1051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce4b/4832366/27d7301bc4bc/PROS-75-1051-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce4b/4832366/b0485042fd32/PROS-75-1051-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce4b/4832366/609024911a8c/PROS-75-1051-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce4b/4832366/7c7d2f4406e7/PROS-75-1051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce4b/4832366/27d7301bc4bc/PROS-75-1051-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce4b/4832366/b0485042fd32/PROS-75-1051-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce4b/4832366/609024911a8c/PROS-75-1051-g004.jpg

相似文献

1
Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India.印度北部前列腺癌患者中ETS和非ETS畸变的分子特征分析。
Prostate. 2015 Jul 1;75(10):1051-62. doi: 10.1002/pros.22989. Epub 2015 Mar 23.
2
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.1577例原发性前列腺癌的特征分析揭示了分子亚型的新生物学和临床病理见解。
Eur Urol. 2015 Oct;68(4):555-67. doi: 10.1016/j.eururo.2015.04.033. Epub 2015 May 8.
3
Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue.采用 ERG、SPINK1、ETV1 和 ETV4 基因表达谱对全器官前列腺根治性切除术组织进行早期前列腺癌的克隆评估。
Prostate. 2020 Jan;80(1):38-50. doi: 10.1002/pros.23914. Epub 2019 Oct 4.
4
Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer.PTEN、ERG、SPINK1 和 AR 在去势抵抗性前列腺癌中的相互作用和关系。
Histopathology. 2012 Mar;60(4):645-52. doi: 10.1111/j.1365-2559.2011.04116.x. Epub 2012 Jan 19.
5
Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma.新型双染免疫组化方法检测前列腺癌中 ERG-PTEN 和 ERG-SPINK1 状态。
Mod Pathol. 2013 Jun;26(6):835-48. doi: 10.1038/modpathol.2012.234. Epub 2013 Jan 25.
6
Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer.用于原位检测前列腺癌中ETV1、ETV4和ETV5基因融合的新型RNA杂交方法。
Appl Immunohistochem Mol Morphol. 2014 Sep;22(8):e32-40. doi: 10.1097/PAI.0000000000000095.
7
PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer.PTEN 基因缺失是前列腺癌中与 ERG 基因重排相关的早期事件。
BJU Int. 2011 Feb;107(3):477-85. doi: 10.1111/j.1464-410X.2010.09470.x.
8
Evidence for molecular differences in prostate cancer between African American and Caucasian men.非裔美国男性和白种男性前列腺癌分子差异的证据。
Clin Cancer Res. 2014 Sep 15;20(18):4925-34. doi: 10.1158/1078-0432.CCR-13-2265. Epub 2014 Jul 23.
9
The role of SPINK1 in ETS rearrangement-negative prostate cancers.SPINK1在ETS重排阴性前列腺癌中的作用。
Cancer Cell. 2008 Jun;13(6):519-28. doi: 10.1016/j.ccr.2008.04.016.
10
Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.雄激素非依赖性转移性前列腺癌中TMPRSS2-ETS基因畸变的特征分析
Cancer Res. 2008 May 15;68(10):3584-90. doi: 10.1158/0008-5472.CAN-07-6154.

引用本文的文献

1
Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing.前列腺导管腺癌,具有新型基因改变,通过下一代测序技术进行特征描述。
Curr Oncol. 2024 Mar 19;31(3):1556-1561. doi: 10.3390/curroncol31030118.
2
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer.组织学不可知药物在转移性去势抵抗性前列腺癌治疗中的作用。
Int J Mol Sci. 2022 Aug 1;23(15):8535. doi: 10.3390/ijms23158535.
3
Androgen-Driven Fusion Genes and Chimeric Transcripts in Prostate Cancer.

本文引用的文献

1
Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer.用于原位检测前列腺癌中ETV1、ETV4和ETV5基因融合的新型RNA杂交方法。
Appl Immunohistochem Mol Morphol. 2014 Sep;22(8):e32-40. doi: 10.1097/PAI.0000000000000095.
2
Evidence for molecular differences in prostate cancer between African American and Caucasian men.非裔美国男性和白种男性前列腺癌分子差异的证据。
Clin Cancer Res. 2014 Sep 15;20(18):4925-34. doi: 10.1158/1078-0432.CCR-13-2265. Epub 2014 Jul 23.
3
Increased association of the ERG oncoprotein expression in advanced stages of prostate cancer in Filipinos.
前列腺癌中雄激素驱动的融合基因和嵌合转录本
Front Cell Dev Biol. 2021 Feb 9;9:623809. doi: 10.3389/fcell.2021.623809. eCollection 2021.
4
Molecular characterization of prostate cancer in Middle Eastern population highlights differences with Western populations with prognostic implication.中东人群前列腺癌的分子特征凸显出与西方人群的差异,具有预后意义。
J Cancer Res Clin Oncol. 2020 Jul;146(7):1701-1709. doi: 10.1007/s00432-020-03221-x. Epub 2020 Apr 30.
5
Molecular Underpinnings Governing Genetic Complexity of ETS-Fusion-Negative Prostate Cancer.调控 ETS 融合阴性前列腺癌遗传复杂性的分子基础。
Trends Mol Med. 2019 Nov;25(11):1024-1038. doi: 10.1016/j.molmed.2019.07.001. Epub 2019 Jul 25.
6
Prevalence and clinical application of fusion in Asian prostate cancer patients: a large-sample study in Chinese people and a systematic review.融合在亚洲前列腺癌患者中的流行情况和临床应用:中国人的大样本研究和系统评价。
Asian J Androl. 2020 Mar-Apr;22(2):200-207. doi: 10.4103/aja.aja_45_19.
7
Bad Tumors Made Worse: SPINK1.恶性肿瘤恶化:丝氨酸蛋白酶抑制剂Kazal型1(SPINK1)
Front Cell Dev Biol. 2019 Feb 4;7:10. doi: 10.3389/fcell.2019.00010. eCollection 2019.
8
Epigenetic Silencing of miRNA-338-5p and miRNA-421 Drives SPINK1-Positive Prostate Cancer.表观遗传沉默的 miRNA-338-5p 和 miRNA-421 驱动 SPINK1 阳性前列腺癌。
Clin Cancer Res. 2019 May 1;25(9):2755-2768. doi: 10.1158/1078-0432.CCR-18-3230. Epub 2018 Dec 26.
9
Status of - fusion in prostate cancer patients from India: correlation with clinico-pathological details and Met160Val polymorphism.印度前列腺癌患者中-融合的状态:与临床病理细节及Met160Val多态性的相关性
Prostate Int. 2018 Dec;6(4):145-150. doi: 10.1016/j.prnil.2018.03.004. Epub 2018 Mar 26.
10
Differential expression of Annexin 2, SPINK1, and Hsp60 predict progression of prostate cancer through bifurcated WHO Gleason score categories in African American men.膜联蛋白2、丝氨酸蛋白酶抑制剂Kazal型1和热休克蛋白60的差异表达通过美国非裔男性的世界卫生组织 Gleason 评分分类预测前列腺癌的进展。
Prostate. 2018 Aug;78(11):801-811. doi: 10.1002/pros.23537. Epub 2018 Apr 22.
菲律宾人前列腺癌晚期 ERG 癌蛋白表达增加。
Prostate. 2014 Aug;74(11):1079-85. doi: 10.1002/pros.22791. Epub 2014 Jun 9.
4
Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization--a correlative study with urine PCA3 and TMPRSS2-ERG.应用 RNA 原位杂交技术评估前列腺癌组织 PCA3 表达——与尿 PCA3 和 TMPRSS2-ERG 的相关性研究。
Mod Pathol. 2014 Apr;27(4):609-20. doi: 10.1038/modpathol.2013.169. Epub 2013 Sep 27.
5
Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients from India.印度前列腺癌患者中 ERG 癌基因改变的低频率。
J Cancer. 2013 Jul 5;4(6):468-72. doi: 10.7150/jca.6568. Print 2013.
6
Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.前列腺癌中 ETV1 和 ETV4 的新型 5'融合伙伴。
Neoplasia. 2013 Jul;15(7):720-6. doi: 10.1593/neo.13232.
7
Advancing precision medicine for prostate cancer through genomics.通过基因组学推进前列腺癌精准医学。
J Clin Oncol. 2013 May 20;31(15):1866-73. doi: 10.1200/JCO.2012.45.3662. Epub 2013 Apr 15.
8
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.ETV1 调控雄激素代谢并促进靶向小鼠和患者的侵袭性前列腺癌。
Genes Dev. 2013 Mar 15;27(6):683-98. doi: 10.1101/gad.211011.112.
9
Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma.新型双染免疫组化方法检测前列腺癌中 ERG-PTEN 和 ERG-SPINK1 状态。
Mod Pathol. 2013 Jun;26(6):835-48. doi: 10.1038/modpathol.2012.234. Epub 2013 Jan 25.
10
The promise of dual targeting Akt/mTOR signaling in lethal prostate cancer.双重靶向Akt/mTOR信号通路治疗致命性前列腺癌的前景。
Oncotarget. 2012 Dec;3(12):1483-4. doi: 10.18632/oncotarget.771.